Yang X, Zheng X, Hu S, Huang J, et al. Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis. BMC Cancer 2024;24:654.
PMID: 38811891